wc2022qualifiersasia| Brother Technology: The wholly-owned subsidiary obtained CEP certificate for iopamidol API

News summary

[Brother Technology: The wholly-owned subsidiary obtained CEP certificate for iopamidol API] Securities Times e Company Newswc2022qualifiersasia, Brother Technology (002562) announced on the evening of May 19 that its wholly-owned subsidiary Brother Pharmaceutical recently received an issue from the European Medicines Quality Administrationwc2022qualifiersasiaEuropean Pharmacopoeia Certificate of Suitability for Drug Substance (referred to as "C")wc2022qualifiersasia.wc2022qualifiersasia..

Newsletter text

[Brother Technology: The wholly-owned subsidiary obtains CEP certificate for iopamidol API] Securities Times e Company News, Brother Technology (002562) announced on the evening of May 19 that the wholly-owned subsidiary Brother Pharmaceutical recently received a certificate of suitability for the API issued by the European Administration for the Quality of Medicines.(referred to as the "CEP Certificate"), the name of the API is IOPAMIDOL/Iopamidol, which indicates that the company's API can be sold in international markets that recognize the CEP certificate. Iopamidol is mainly used clinically for lumbar, thoracic and cervical myelography, cerebral angiography, peripheral arterial and venous angiography, cardiovascular angiography, coronary angiography, urography, arthrography and CT enhanced scanning.